Reference papers of the commonly used drugs in the neonatal intensive care This Egyptian Neonatal Pharmacopoeia started life in 2008 as loose A5 Instructions, or ideas contained in the material herein. Negligence or otherwise, or from any use or operation of any methods, products, To the fullest extent of the law, the author does not assume any liabilityįor any injury and/or damage to persons or property as a matter of products liability, Their own experience and knowledge of their patients, to make diagnoses, to determineĭosages and the best treatment for each individual patient, and to take all appropriate It is the responsibility of practitioners, relying on Of administration, and contraindications. To be administered, to verify the recommended dose or formula, the method and duration Information provided (i) on procedures featured or (ii) by the manufacturer of each product Or pharmaceutical products identified, readers are advised to check the most current
NOTI ARANDAS PROFESSIONAL
Including parties for whom they have a professional responsibility. Information or methods they should be mindful of their own safety and the safety of others, Information, methods, compounds, or experiments described herein. Practitioners and researchers mustĪlways rely on their own experience and knowledge in evaluating and using any Practices, or medical treatment may become necessary. As new research andĮxperience broaden our understanding, changes in research methods, professional Knowledge and best practice in this field are constantly changing. Permission, and arrangements can be sent to the authors Reproduced or transmitted in any form or by any means,Įlectronic or mechanical, including photocopying, recording, orĪny information storage and retrieval system, without Cobyright 2015 by Maged Zakaria Mahmoud Ali IBRAHIMĪll rights reserved.